SNCA and Parkinson disease: Their N-isobutyryl-L-cysteine (L-NIBC) protected GNP nanoclusters administered to both in vitro PD cell line models and a murine PD model effectively ameliorated alpha-synuclein (alpha-Syn) fibrillation and reduced behavioral disorder phenotypes.